Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins
出版年份 2023 全文链接
标题
Potentiation of apoptosis in drug-resistant mantle cell lymphoma cells by MCL-1 inhibitor involves downregulation of inhibitor of apoptosis proteins
作者
关键词
-
出版物
Cell Death & Disease
Volume 14, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-02
DOI
10.1038/s41419-023-06233-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Review of the Current Impact of Inhibitors of Apoptosis Proteins and Their Repression in Cancer
- (2022) Pierina Cetraro et al. Cancers
- TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
- (2022) Vivian Changying Jiang et al. Molecular Cancer
- MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
- (2021) Michelle Y. Wang et al. Blood Cancer Journal
- Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma
- (2021) Shaojun Zhang et al. Nature Communications
- Pharmacologic Targeting of Mcl-1 Induces Mitochondrial Dysfunction and Apoptosis in B-Cell Lymphoma Cells in a TP53- and BAX-Dependent Manner
- (2021) Tingting Liu et al. CLINICAL CANCER RESEARCH
- The antibody drug conjugate VLS-101 targeting ROR1 is effective in CAR T-resistant mantle cell lymphoma
- (2021) Vivian Changying Jiang et al. Journal of Hematology & Oncology
- Targeting MCL-1 in hematologic malignancies: Rationale and progress
- (2020) AndrewH. Wei et al. BLOOD REVIEWS
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibition
- (2020) Bing Z. Carter et al. HAEMATOLOGICA
- A Delicate Balance - The BCL-2 Family and its Role in Apoptosis, Oncogenesis, and Cancer Therapeutics
- (2019) Tristan Knight et al. BIOCHEMICAL PHARMACOLOGY
- BCL2 blockade overcomes MCL1 resistance in multiple myeloma
- (2019) Ka Tat Siu et al. LEUKEMIA
- Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives
- (2019) Hui Cong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management
- (2019) Preetesh Jain et al. AMERICAN JOURNAL OF HEMATOLOGY
- Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
- (2019) Liang Zhang et al. Science Translational Medicine
- Mitochondrial Reprogramming Underlies Resistance to BCL-2 Inhibition in Lymphoid Malignancies
- (2019) Romain Guièze et al. CANCER CELL
- Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas
- (2018) Lan V. Pham et al. CLINICAL CANCER RESEARCH
- Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
- (2018) Toby A. Eyre et al. HAEMATOLOGICA
- Pleiotropic Action of Novel Bruton's Tyrosine Kinase Inhibitor BGB-3111 in Mantle Cell Lymphoma
- (2018) Carrie J. Li et al. MOLECULAR CANCER THERAPEUTICS
- Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
- (2018) Adriana E. Tron et al. Nature Communications
- Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
- (2017) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathways and mechanisms of venetoclax resistance
- (2017) Prithviraj Bose et al. LEUKEMIA & LYMPHOMA
- Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma
- (2017) Xiaohong Zhao et al. Nature Communications
- Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53
- (2014) G. L. Kelly et al. GENES & DEVELOPMENT
- SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy
- (2014) Eva Rettinger et al. Frontiers in Pediatrics
- Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration
- (2012) Rhonda M. Perciavalle et al. NATURE CELL BIOLOGY
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started